NCT00694668

Brief Summary

Background: In recent years, there has been a marked rise in the frequency of young people engaging in Deliberate Self-Harm (DSH). DSH refers to all kinds of self-harming behaviour, with and without suicidal intent. Early identification and treatment of persons who engaged in DSH is important because every episode of DSH increases the risk of future episodes and, eventually, suicide. A number of comprehensive treatment programs have been developed and proven to be effective in reducing DSH in adults. Especially the modification of inadequate emotion regulation strategies seems to be essential in the prevention of future episodes of DSH. The first short-term results of a Dutch time-limited and structured individual cognitive-behavioral treatment (CBT) for DSH in adolescents and young adults also showed positive effects on repetition of DSH and associated problems. Objective: To study the effects and costs of the total individual CBT package and one of the components of the total CBT treatment package (i.e. mindfulness training) in a group format compared to Treatment-as-Usual (TAU) on the short and long term. Design: Multi-center randomized controlled clinical trial with repeated measurements at baseline (M0),and posttreatment (M6)), 12 (M12) and 18 months (M18) after baseline. Procedure: Young persons aged 15-35 who recently have engaged in DSH and have been referred to the Leiden University Medical Centre, the mental health centre Rivierduinen or the University Medical Centre St. Radboud following an act of DSH will be invited to participate. Persons reporting severe psychiatric disorders requiring intensive inpatient treatment or serious cognitive impairments will be excluded. Interventions: Participants are randomly allocated to CBT, Mindfulness-Based Cognitive Therapy(MBCT) or Treatment-as-Usual (TAU). The CBT treatment consists of up to 12 weekly sessions of individual treatment mainly consisting of emotion regulations skills, cognitive restructuring, and behavioural skills training. The MBCT training consists of 8 2-hour sessions in a group format within a three months time frame. Outcome measures: The same outcome measures to assess the clinical effects of treatment as in the previous study will be used (repetition of DSH, depression (BDI-II), anxiety (SCL-90), self-concept(RSC-Q), and suicide cognitions (SCS)) allowing a historical comparison of treatment effectiveness across both randomized clinical trials. In addition at all assessments health-related quality of life, use of medical resources and loss of productivity will be assessed (EuroQol, VAS and TTO). In addition,problems in emotion regulation (an important risk mechanism for repetition of DSH) will be assessed before and after treatment. Economic evaluation: Differences in societal costs (intervention, other (health) care and productivity)will be compared to differences in the frequency of DSH and quality adjusted life years (EuroQol, VAS and TTO). Data-analysis/power: Based on our previous study at least a medium effect of treatment on repetition of DSH may be expected. Assuming a medium effect of one of the treatments compared to TAU (delta =.75) and an attrition rate of about 20 %, at least 42 patients per study arm are needed to detect a minimal clinical relevant difference in repetition of DSH with a power of 80% and alpha set at .05.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started May 2008

Typical duration for phase_2

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 5, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 10, 2008

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2010

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

November 6, 2009

Status Verified

November 1, 2009

Enrollment Period

2.5 years

First QC Date

June 5, 2008

Last Update Submit

November 5, 2009

Conditions

Keywords

Deliberate Self-HarmSelf-Injurious BehaviourSuicidal BehaviourCognitive behavioural therapyMindfulness Based cognitive therapy

Outcome Measures

Primary Outcomes (1)

  • Repetition of DSH, measured by the suicide attempt and self injury interview (SASII). Frequency, method and other characteristics of deliberate self-harm and suicide attempts are assessed.

    M0, M6, M12, M18

Secondary Outcomes (15)

  • depression, as measured by the Beck depression Inventory II

    M0, M6, M12, M18

  • Anxiety, as measured by the symptom checklist '90

    M0, M6, M12, M18

  • Hostility, as measured by the symptom checklist '90

    M0, M6, M12, M18

  • Self-concept, as measured by the Robson self-concept questionnaire

    M0, M6, M12, M18

  • Suicidal cognitions, as measured by the suicidal cognitions scale

    M0, M6, M12, M18

  • +10 more secondary outcomes

Study Arms (2)

1

EXPERIMENTAL

Cognitive Behavioural Treatment

Behavioral: Cognitive Behavioral treatment

2

EXPERIMENTAL

Mindfulness Based Cognitive Therapy-training

Behavioral: Mindfulness based cognitive therapy

Interventions

Brief cognitive behavioral therapy (12 sessions)

1

9 sessions MBCT in a group-format (up to 8 persons)

2

Eligibility Criteria

Age15 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Recently engaged in an act of DSH including overdose of medication, ingestion of chemical substances and self-inflicted injuries according to the definition which is used in the WHO/Euro Multicentre Study on parasuicide:"An act with non-fatal outcome in which an individual deliberately initiates a non-habitual behavior, that without intervention from other will cause self-harm, or deliberately ingests a substance in excess of the prescribed or generally recognized dosage, and which is aimed at realizing changes that the person desires via the actual or expected physical consequences"(Platt et al., 1992).
  • Aged between 15 and 35
  • Living in the region of Leiden or Nijmegen

You may not qualify if:

  • Severe psychiatric disorder or substance abuse requiring intensive inpatient treatment
  • Serious cognitive impairments
  • Not be able to converse in Dutch

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University Medical Centre St. Radboud

Nijmegen, Gelderland, Netherlands

RECRUITING

Leiden University Medical Centre

Leiden, South Holland, Netherlands

RECRUITING

Rivierduinen Mental Health Centre

Leiden, South Holland, Netherlands

RECRUITING

MeSH Terms

Conditions

Self-Injurious Behavior

Interventions

Mindfulness-Based Cognitive Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Philip Spinhoven, Prof. dr.

    Leiden University, Institute for Psychological Research

    STUDY CHAIR
  • Arnold A.P. van Emmerik, Dr.

    Leiden University, Clinical Psychology Unit

    STUDY DIRECTOR
  • Anne E. van Giezen, Dr.

    Leiden University, Institute for Psychological Research, Clinical Psychology Unit

    STUDY DIRECTOR
  • Anne E.M. Speckens, Prof. dr.

    Radboud University Medical Center

    STUDY CHAIR
  • Suzanne de Klerk, MSc.

    Leiden University, Institute for Psychological Research, Clinical Psychology Unit

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Suzanne de Klerk, MSc.

CONTACT

Anne van Giezen, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 5, 2008

First Posted

June 10, 2008

Study Start

May 1, 2008

Primary Completion

November 1, 2010

Study Completion

October 1, 2012

Last Updated

November 6, 2009

Record last verified: 2009-11

Locations